Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Robert Trainor Joins Covington’s Life Sciences Practice

May 13, 2013

WASHINGTON, DC, May 13, 2013Robert J. Trainor, former executive vice president and general counsel of Brussels-based UCB S.A., joins Covington & Burling today as senior of counsel in the firm’s New York City office. He will advise clients on a broad range of corporate, policy, and litigation matters affecting the pharmaceutical industry and other corporate clients.

During his tenure at UCB, the company significantly expanded its business and its research and development efforts. Mr. Trainor led the legal team for the company’s $5.6 billion 2006 acquisition of Schwarz Pharma AG.

“Bob brings a unique experience in the pharmaceutical industry,” said Richard Kingham, co-chair of the firm’s life sciences practice. “He will be an invaluable asset for clients, especially in the international arena.”

Mr. Trainor served in senior in-house legal roles with Schering-Plough, and Johnson & Johnson. Earlier in his career, Mr. Trainor served on the staff of the U.S. House Judiciary Committee.

“It’s an exciting opportunity to join Covington’s premier life sciences and corporate practices,” Mr. Trainor said. “I look forward to working with clients to help them build their businesses around the globe.”

Mr. Trainor earned his undergraduate and law degrees from Villanova University.

Share this article: